Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Cash Flow Quality Index
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Cash Flow Quality Index of -0.45x as of December 2025. Operating cash flow of CN¥-12.88 Million is below net income of CN¥28.63 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Guangdong Taienkang Pharmaceutical Co. L balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Guangdong Taienkang Pharmaceutical Co. Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Guangdong Taienkang Pharmaceutical Co. L tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
Year-by-year earnings quality comparison for Guangdong Taienkang Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see market cap of Guangdong Taienkang Pharmaceutical Co. L.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.45x | CN¥-12.88 Million | CN¥28.63 Million | ▼ -154.5% |
| 2024 | 0.83x | CN¥89.33 Million | CN¥108.22 Million | ▲ +41.4% |
| 2023 | 0.58x | CN¥93.53 Million | CN¥160.20 Million | ▼ -31.5% |
| 2022 | 0.85x | CN¥148.81 Million | CN¥174.61 Million | ▼ -14.7% |
| 2021 | 1.00x | CN¥120.02 Million | CN¥120.07 Million | ▲ +28.1% |
| 2020 | 0.78x | CN¥125.53 Million | CN¥160.83 Million | ▼ -43.2% |
| 2019 | 1.37x | CN¥75.44 Million | CN¥54.90 Million | — |